DNA双链断裂(double-strand breaks,DSBs)修复对于保证基因组完整性以及维持细胞的平衡稳定性起着关键作用。p53结合蛋白1(p53-binding protein 1,53BP1)是针对产生的双链断裂损伤做出反应的重要调控因子。目前,研究人员对于53BP1被招...DNA双链断裂(double-strand breaks,DSBs)修复对于保证基因组完整性以及维持细胞的平衡稳定性起着关键作用。p53结合蛋白1(p53-binding protein 1,53BP1)是针对产生的双链断裂损伤做出反应的重要调控因子。目前,研究人员对于53BP1被招募到受损的染色质上的过程,以及53BP1在DSBs修复过程中阻止同源重组(homologous recombination,HR)的同时推动非同源末端连接(non-homologous end-joining,NHEJ)的过程,已经有了新的认识。并且,近期的研究结果启发科学家们提出了一种新的模型,即53BP1的招募需要直接识别DSBs特异性的组蛋白密码,而53BP1发挥作用时的通路选择则与BRCA1蛋白的拮抗作用有关。结合近年来有关53BP1的研究进展,主要综述了53BP1的结构与功能特点,其作为调控因子在DSBs修复过程中发挥的作用,以及53BP1达到有效聚集的方式。展开更多
Sepsis, which refers to a systemic inflammatory response syndrome resulting from a microbial infection, represents the leading cause of death in intensive care units. The pathogenesis of sepsis remains poorly understo...Sepsis, which refers to a systemic inflammatory response syndrome resulting from a microbial infection, represents the leading cause of death in intensive care units. The pathogenesis of sepsis remains poorly understood although it is attributable to dysregulated immune responses orchestrated by innate immune cells that sequentially release early(e.g., tumor necrosis factor(TNF), interleukin-1(IL-1), and interferon-γ(IFN-γ) and late(e.g., high mobility group box 1(HMGB1)) pro-inflammatory mediators. As a ubiquitous nuclear protein, HMGB1 can be passively released from pathologically damaged cells, thereby converging infection and injury on commonly dysregulated inflammatory responses. We review evidence that supports extracellular HMGB1 as a late mediator of inflammatory diseases and discuss the potential of several Chinese herbal components as HMGB1-targeting therapies. We propose that it is important to develop strategies for specifically attenuating injury-elicited inflammatory responses without compromising the infection-mediated innate immunity for the clinical management of sepsis and other inflammatory diseases.展开更多
基金supported by grants from the National Center of Complementary and Alternative Medicine (NCCAM, R01AT005076)the National Institute of General Medical Sciences (NIGMS, R01GM063075)
文摘Sepsis, which refers to a systemic inflammatory response syndrome resulting from a microbial infection, represents the leading cause of death in intensive care units. The pathogenesis of sepsis remains poorly understood although it is attributable to dysregulated immune responses orchestrated by innate immune cells that sequentially release early(e.g., tumor necrosis factor(TNF), interleukin-1(IL-1), and interferon-γ(IFN-γ) and late(e.g., high mobility group box 1(HMGB1)) pro-inflammatory mediators. As a ubiquitous nuclear protein, HMGB1 can be passively released from pathologically damaged cells, thereby converging infection and injury on commonly dysregulated inflammatory responses. We review evidence that supports extracellular HMGB1 as a late mediator of inflammatory diseases and discuss the potential of several Chinese herbal components as HMGB1-targeting therapies. We propose that it is important to develop strategies for specifically attenuating injury-elicited inflammatory responses without compromising the infection-mediated innate immunity for the clinical management of sepsis and other inflammatory diseases.
